Showing results (51-60 of 83) with videos related to
Sort By:
Pageof 9
Arxiv|June 12, 2026
Modeling hepatitis D virus kinetics during bulevirtide monotherapy: challenges and solutionsAdquate Mhlanga, Louis Shekhtman, Ashish Goyal, et al.Journal of Hepatology|August 16, 2022
Bulevirtide monotherapy for 48 weeks in patients with HDV-related compensated cirrhosis and clinically significant portal hypertensionElisabetta Degasperi, Maria Paola Anolli, Sara Colonia Uceda Renteria, et al.Gut|June 17, 2026
Course and clinical outcomes of chronic hepatitis delta: a longitudinal analysis of 565 patients from the D-SOLVE and HDV-1000 consortiaHabiba Kamal, Elisabetta Degasperi, Monica Radu, et al.Alimentary Pharmacology & Therapeutics|November 21, 2024
Development and Validation of a PIVKA-II-Based Model for HCC Risk Stratification in Patients With HCV-Related Cirrhosis Successfully Treated With DAAGian Paolo Caviglia, Piero Fariselli, Roberta D'Ambrosio, et al.Alimentary Pharmacology & Therapeutics|April 21, 2026
Baseline HDV-RNA Levels Could Stratify Clinical Risk Before, But Not After, Cirrhosis in Chronic Hepatitis D: A Multicentre European StudyAdriana Palom, Elisabetta Degasperi, Barbara Coco, et al.Antiviral Therapy|April 4, 2020
Real-life use of elbasvir/grazoprevir in adults and elderly patients: a prospective evaluation of comedications used in the PITER cohortMaria Giovanna Quaranta, Stefano Rosato, Luigina Ferrigno, et al.JHEP Reports : Innovation in Hepatology|April 6, 2026
Impact of Hepatocellular Carcinoma on the risk of liver decompensation: a comparative analysis of patients with and without HCC: Role of HCC in liver decompensationAndrea Martini, Massimo Iavarone, Roberta D'Ambrosio, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 20, 2022
Spike-specific humoral and cellular immune responses after COVID-19 mRNA vaccination in patients with cirrhosis: A prospective single center studyMassimo Iavarone, Giulia Tosetti, Floriana Facchetti, et al.Hepatology (Baltimore, Md.)|March 13, 2024
Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis-A real-world case seriesChristopher Dietz-Fricke, Elisabetta Degasperi, Mathias Jachs, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 11, 2025
Management of Hepatitis B virus infection in patients on treatment with immunosuppressants or immunomodulators: Position Paper of Associazione Italiana Studio del Fegato (AISF), Associazione Italiana di Oncologia Medica (AIOM), Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO), Società Italiana di Reumatologia (SIR), Società Italiana Trapianti d'Organo (SITO), Società Italiana di Gastroenterologia (SIGE), Società Italiana di Malattie Infettive e Tropicali (SIMIT)Mauro Viganò, Roberta D'Ambrosio, Ciro Celsa, et al.Pageof 9